Your browser doesn't support javascript.
loading
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
Nguyen, Nga; Wan, Guihong; Ugwu-Dike, Pearl; Alexander, Nora A; Raval, Neel; Zhang, Shijia; Jairath, Ruple; Phillipps, Jordan; Leung, Bonnie; Roster, Katie; Seo, Jayhyun; Lu, Chenyue; Tang, Kimberly; Choi, Min Seok; DeSimone, Mia S; Theodosakis, Nicholas; Amadife, Munachimso; Cox, Nevada; Le, Thomas K; Liu, Feng; Chen, Wenxin; Bai, Xue; Boland, Genevieve; Liu, David; Hurlbert, Marc S; LeBoeuf, Nicole; Reynolds, Kerry L; Yu, Kun-Hsing; Tsao, Hensin; Asgari, Maryam; Gusev, Alexander; Kwatra, Shawn G; Semenov, Yevgeniy R.
Afiliación
  • Nguyen N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Wan G; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Ugwu-Dike P; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Alexander NA; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Raval N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Zhang S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Jairath R; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Phillipps J; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Leung B; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Roster K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Seo J; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Lu C; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Tang K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Choi MS; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • DeSimone MS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Theodosakis N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Amadife M; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Cox N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Le TK; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Liu F; School of Systems and Enterprises, Stevens Institute of Technology, Hoboken, New Jersey.
  • Chen W; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Bai X; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Boland G; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
  • Liu D; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hurlbert MS; Melanoma Research Alliance, Washington, District of Columbia.
  • LeBoeuf N; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Reynolds KL; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Yu KH; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
  • Tsao H; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Asgari M; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.
  • Gusev A; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: ysemenov@mgh.harvard.edu.
J Am Acad Dermatol ; 88(6): 1308-1316, 2023 06.
Article en En | MEDLINE | ID: mdl-36828138
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article